Self-reported adherence to antiretroviral treatment among HIV-infected people in Central China

AIDS Patient Care and STDs

Volumn 22, Issue 1, 2008, Pages 71-80

  Wang, Honghong ^a   He, Gouping ^a   Li, Xianhong ^a   Yang, Aiyun ^a   Chen, Xi ^a,b   Fennie, Kristopher P ^c   Williams, Ann Bartley ^c,d  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Hunan Provincial CDC   (China)

^c YALE UNIVERSITY   (United States)

^d YALE UNIVERSITY SCHOOL OF NURSING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIAMORPHINE; DIDANOSINE; EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL RESISTANCE; ARTICLE; CHINA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PATIENT SATISFACTION; QUESTIONNAIRE; REMINDER SYSTEM; SELF REPORT; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; AGED; ANTI-HIV AGENTS; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; QUESTIONNAIRES; REVERSE TRANSCRIPTASE INHIBITORS; SELF DISCLOSURE;

EID: 38149001641     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2007.0047     Document Type: Article

References (28)

1. Hsiao WC. Transformation of health care in China. N Eng J Med 1984;310:932-936.
2. Shao CG, Liang GJ, Gong XD, Chen XS. Retrospects and prospects on STDs surveillance in China. Chin J STD/AIDS Prev Cont 2002;8:247.
3. Xu WY, Shao CG. Trends and causes of STD epidemic and its preventive and control measures. China Med News 1997;5:9.
4. State Council of the People's Republic of China. China's action plan for reducing and preventing the spread of HIV/AIDS (2006-2010) [in Chinese]. State Council Document, 2006, Number 13. Beijing, 2006.
5. Ministry of Health of China, UNAIDS, WHO. 2005 update on the HIV/AIDS epidemic and response in China. Beijing: Ministry of Health, 2006.
6. Cao YZ, Lu HZ Care of HIV patients in China. Cell Res 2005;15:883-890.
7. Sheng Jie. Brief Introduction of ARV Treatment in China on 2003. www.chain.net.cn/article.php?articleID=1799 in (Last accessed June 2005).
8. Wu Z, Sullivan SG, Wang Y, Rotheram-Borus MJ, Detels R. Evolution of China's response to HIV/AIDS. Lancet; 2007;369:679-690.
9. Ma GH. China AIDS experts worried about national AIDS programme. Lancet Infect Dis 2004;4:539.
10. Parienti J, Massari V, Descamps D, Vabret A, Bouvet E, Larouze B. Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine or efavirenz-based antiretroviral therapy. Clin Infect Dis 2004;38:1311-1316.
11. Spacek LA, Shihab HM, Kamya MR, et al. Response to antiretroviral therapy in HIV-infected patients attending a public, urban cinic in Kampala, Uganda. Clin Infect Dis 2006;42:252-259.
12. Na H, Detels R. The HIV epidemic in China: History, response, and challenges. Cell Res 2005;15:825-832.
13. Mannheimer SB, Matts J, Telzak E, et al. Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence. AIDS Care 2005;17:10-22.
14. Giordano TP, Guzman D, Clark R. Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials 2004;5:74-79.
15. Turner BJ, Hecht FM. Improving on a coin toss to predict patient adherence to medications. Ann Intern Med 2001;134:1004-1006.
16. Gao X, Nau DP, Rosenbluth SA, Scott V. The relationship of disease severity, health beliefs and medication adherence among HIV patients. AIDS Care 2000;12:387-398.
17. Deschamps AE, Graeve VD, Wijngaerden EV, et al. Prevalence and correlates of nonadherence to anti-retroviral therapy in a population of HIV patients using medication event monitoring system. AIDS Patient Care STDs 2004;18:644-657.
18. Melbourne KM, Geletko SM, Brown SL, Willey-Lessne C, Chase S, Fisher A. Medication adherence in patients with HIV infection: A comparison of two measurement methods. AIDS Read 1999;9:329-338.
19. Lanièce I, Ciss M, Desclaux A, et al. Adherence to HAART and its principal determinants in a cohort of Senegalese adults. AIDS 2003;17:S103-S108.
20. Zhang K. AIDS survey in villages of Henan and Anhui from 2004 to 2006. www.hnyg.com.cn/bbs/dispbbs.asp?boardid=35&ID=1454, (Last accessed January 5, 2007).
21. Fong OW, Ho CF, Fung LY, et al. Determinants of adherence to highly active antiretroviral therapy in Chinese HIV/AIDS patients. HIV Med 2003;4:133-138.
22. Aloisi MS, Arici C, Balzano R, et al. Behavioral correlates of adherence to antiretroviral therapy. J Acquir Immune Defic Syndr 2002;31:S145-S148.
23. Berg KM, Demas PA, Howard AA, Schoenbaum EE, Gourevitch MN, Arnsten JH. Gender differences in factors associated with adherence to antiretroviral therapy. J Gen Intern Med 2004;19:1111-1117.
24. Zhao C, Liu Z, Zhao D, et al. Drug abuse in China. Ann NY Acad Sci 2004;1025: 439-445.
25. Wu AW, Snyder CF, Huang IC. A randomized trial of the impact of a programmable medication reminder device on quality of life in patients with AIDS. AIDS Patient Care STDs 2006;20:773-781.
26. Reynolds NR. Adherence to antiretroviral therapies: state of the science. Curr HIV Res 2004;2:207-214.
27. Ammassari A, Trotta MP, Murri R, et al. Correlates and predictors of adherence to highly active anti-retroviral therapy: Overview of published literature. J Acquir Immune Defic Syndr 2002;31:S123-S127.
28. Miller LG, Liu H, Hays RD, et al. Knowledge of anti-retroviral regimen dosing and adherence: A longitudinal study. Clin Infect Dis 2003;36:514-518.